Literature DB >> 10394151

Reoperation for carotid stenosis is as safe as primary carotid endarterectomy.

B B Hill1, C Olcott, R L Dalman, E J Harris, C K Zarins.   

Abstract

PURPOSE: Patients with recurrent carotid artery stenosis are sometimes referred for carotid angioplasty and stenting because of reports that carotid reoperation has a higher complication rate than primary carotid endarterectomy. The purpose of this study was to determine whether a difference exists between outcomes of primary carotid endarterectomy and reoperative carotid surgery.
METHODS: Medical records were reviewed for all carotid operations performed from September 1993 through March 1998 by vascular surgery faculty at a single academic center. The results of primary carotid endarterectomy and operation for recurrent carotid stenosis were compared.
RESULTS: A total of 390 operations were performed on 352 patients. Indications for primary carotid endarterectomy (n = 350) were asymptomatic high-grade stenosis in 42% of the cases, amaurosis fugax and transient ischemic symptoms in 35%, global symptoms in 14%, and previous stroke in 9%. Indications for reoperative carotid surgery (n = 40) were symptomatic recurrent lesions in 50% of the cases and progressive high-grade asymptomatic stenoses in 50%. The results of primary carotid endarterectomy were no postoperative deaths, an overall stroke rate of 1.1% (three postoperative strokes, one preoperative stroke after angiography), and no permanent cranial nerve deficits. The results of operations for recurrent carotid stenosis were no postoperative deaths, no postoperative strokes, and no permanent cranial nerve deficits. In the primary carotid endarterectomy group, the mean hospital length of stay was 2.6 +/- 1. 1 days and the mean hospital cost was $9700. In the reoperative group, the mean length of stay was 2.6 +/- 1.5 days and the mean cost was $13,700. The higher cost of redo surgery is accounted for by a higher preoperative cerebral angiography rate (90%) in redo cases as compared with primary endarterectomy (40%).
CONCLUSION: In this series of 390 carotid operations, the procedure-related stroke/death rate was 0.8%. There were no differences between the stroke-death rates after primary carotid endarterectomy and operation for recurrent carotid stenosis. Operation for recurrent carotid stenosis is as safe and effective as primary carotid endarterectomy and should continue to be standard treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10394151     DOI: 10.1016/s0741-5214(99)70173-4

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

1.  Quality improvement guidelines for the performance of cervical carotid angioplasty and stent placement.

Authors:  John D Barr; John J Connors; David Sacks; Joan C Wojak; Gary J Becker; John F Cardella; Bohdan Chopko; Jacques E Dion; Allan J Fox; Randall T Higashida; Robert W Hurst; Curtis A Lewis; Terence A S Matalon; Gary M Nesbit; J Arliss Pollock; Eric J Russell; David J Seidenwurm; Robert C Wallace
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

2.  Carotid endarterectomy remains the standard of care, even in high-risk surgical patients.

Authors:  Tamer N Boules; Mary C Proctor; Ahmad Aref; Gilbert R Upchurch; James C Stanley; Peter K Henke
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

3.  Stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria.

Authors:  Kristina A Giles; Allen D Hamdan; Frank B Pomposelli; Mark C Wyers; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2010-09-22       Impact factor: 4.268

4.  Carotid stenting versus endarterectomy in patients undergoing reintervention after prior carotid endarterectomy.

Authors:  Margriet Fokkema; Gert Jan de Borst; Brian W Nolan; Ruby C Lo; Robert A Cambria; Richard J Powell; Frans L Moll; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2013-08-22       Impact factor: 4.268

5.  Carotid endarterectomy at the millennium: what interventional therapy must match.

Authors:  Glenn M LaMuraglia; David C Brewster; Ashby C Moncure; David J Dorer; Michael C Stoner; Samir K Trehan; Elizabeth C Drummond; William M Abbott; Richard P Cambria
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.